<DOC>
	<DOCNO>NCT02016196</DOCNO>
	<brief_summary>TIPS use 20 year , mean reduce portal pressure patient cirrhosis portal hypertension relate complication . TIPS prove effective alternative treatment control prevent variceal bleed refractory ascites . The main drawback TIPS procedure progressive overt hepatic encephalopathy ( OHE ) . Three risk factor post-TIPS OHE identify : age 65 year , history previous episode OHE , Child-Pugh score equal 10 . However , incidence post-TIPS OHE patient fulfil criterion remain close 35 % .</brief_summary>
	<brief_title>Rifaximin v Placebo Prevention Encephalopathy Patients Treated TIPS</brief_title>
	<detailed_description>TIPS use 20 year , mean reduce portal pressure patient cirrhosis portal hypertension relate complication . TIPS prove effective alternative treatment control prevent variceal bleed refractory ascites . The main drawback TIPS procedure progressive overt hepatic encephalopathy ( OHE ) . Three risk factor post-TIPS OHE identify : age 65 year , history previous episode OHE , Child-Pugh score equal 10 . However , incidence post-TIPS OHE patient fulfil criterion remain close 35 % . Furthermore , pathogenesis HE general also patient treat TIPS still well understood . Therefore , real challenge discover new molecular mechanism involve pathogenesis OHE well new treatment well prevent risk OHE patient treat TIPS . Observational experimental study suggest microbiota 's role mechanism OHE recently non absorbable antibiotic proven reduce risk recurrence OHE . However , effect drug prevention first episode OHE patient treat TIPS know . In addition , mechanisms beneficial effect rifaximin remain poorly understood .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>cirrhosis TIPS ascit treatment hydrothorax prevention digestive bleeding follow portal hypertension sign consent hepatocellular carcinoma Milan criterion palliative phase cancer Child Pugh score &gt; 12 TIPS indicate indication bellow encephalopathy sign : asterixis confusion Hypersensibility rifaximin , derivated rifamycin Patients treat class antibacterial pregnant woman Patient hepatic transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>TIPS</keyword>
	<keyword>portal pressure</keyword>
	<keyword>rifaximin</keyword>
	<keyword>overt hepatic encephalopathy</keyword>
	<keyword>microbiota</keyword>
</DOC>